Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guy Carpenter is a leading global risk and reinsurance specialist and a subsidiary of Marsh McLennan. The firm provides reinsurance brokering, strategic advisory services, and advanced analytics to insurance and reinsurance companies worldwide. Within the healthcare and life sciences sectors, Guy Carpenter’s Global Health and Life Sciences practices offer specialized risk management solutions, including capital optimization and reinsurance placement for health plans and pharmaceutical companies. The company does not develop therapeutic products or conduct clinical trials; instead, it focuses on managing the financial risks associated with high-cost medical claims and product liability. Its proprietary analytics platforms, such as MetaRisk, help clients quantify and manage complex risks in the healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guy Carpenter.